HEADER LIGASE/LIGASE INHIBITOR 26-OCT-20 7KJN TITLE CRYSTAL STRUCTURE OF HUMAN MDMX IN COMPLEX WITH D-PEPTIDE INHIBITOR TITLE 2 (DPMI-OMEGA) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN MDM4; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: DOUBLE MINUTE 4 PROTEIN,MDM2-LIKE P53-BINDING PROTEIN, COMPND 5 PROTEIN MDMX,P53-BINDING PROTEIN MDM4; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: D-PMI-OMEGA; COMPND 10 CHAIN: B, C; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 9 ORGANISM_TAXID: 32630 KEYWDS MDMX, MDM2-LIKE P53 BINDING PROTEIN, P53-BINDING PROTEIN MDM4, D- KEYWDS 2 PEPTIDE ACTIVATOR OF MDMX, MDMX-D-PEPTIDE COMPLEX, HOST-VIRUS KEYWDS 3 INTERACTION, LIGASE, METAL-BINDING, NUCLEUS, PHOSPHOPROTEIN, PROTO- KEYWDS 4 ONCOGENE, UBL CONJUGATION PATHWAY, ZINC-FINGER, LIGASE-LIGASE KEYWDS 5 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.D.TOLBERT,M.PAZGIER REVDAT 3 15-NOV-23 7KJN 1 REMARK REVDAT 2 18-OCT-23 7KJN 1 REMARK REVDAT 1 17-NOV-21 7KJN 0 JRNL AUTH W.D.TOLBERT,M.PAZGIER JRNL TITL CRYSTAL STRUCTURE OF HUMAN MDMX IN COMPLEX WITH D-PEPTIDE JRNL TITL 2 INHIBITOR (DPMI-OMEGA) JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 3108 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.600 REMARK 3 FREE R VALUE TEST SET COUNT : 184 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 222 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.70 REMARK 3 BIN R VALUE (WORKING SET) : 0.3580 REMARK 3 BIN FREE R VALUE SET COUNT : 16 REMARK 3 BIN FREE R VALUE : 0.3530 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 910 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.18000 REMARK 3 B22 (A**2) : 2.18000 REMARK 3 B33 (A**2) : -7.06000 REMARK 3 B12 (A**2) : 1.09000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.378 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.311 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 40.007 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 927 ; 0.019 ; 0.014 REMARK 3 BOND LENGTHS OTHERS (A): 884 ; 0.026 ; 0.018 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 1243 ; 2.897 ; 1.798 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2053 ; 3.105 ; 1.768 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 102 ; 6.048 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 31 ;43.072 ;22.903 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 127 ;22.749 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 3 ;29.585 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 107 ; 0.178 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1020 ; 0.030 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 197 ; 0.009 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 429 ; 3.172 ; 4.904 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 429 ; 3.171 ; 4.904 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 524 ; 5.022 ; 7.328 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 525 ; 5.019 ; 7.331 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 498 ; 3.637 ; 5.330 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 499 ; 3.634 ; 5.333 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 719 ; 5.894 ; 7.875 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3430 ; 8.587 ;92.995 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3431 ; 8.586 ;92.982 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 24 A 108 REMARK 3 ORIGIN FOR THE GROUP (A): 25.307 -15.283 1.106 REMARK 3 T TENSOR REMARK 3 T11: 0.0348 T22: 0.0682 REMARK 3 T33: 0.0404 T12: 0.0207 REMARK 3 T13: 0.0006 T23: -0.0133 REMARK 3 L TENSOR REMARK 3 L11: 0.9173 L22: 1.0922 REMARK 3 L33: 1.2242 L12: 0.9795 REMARK 3 L13: 0.3959 L23: 0.2151 REMARK 3 S TENSOR REMARK 3 S11: -0.0229 S12: -0.0163 S13: 0.0482 REMARK 3 S21: 0.0122 S22: -0.0228 S23: 0.0343 REMARK 3 S31: 0.0427 S32: -0.0832 S33: 0.0457 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 1 B 12 REMARK 3 ORIGIN FOR THE GROUP (A): 28.303 -21.778 -11.435 REMARK 3 T TENSOR REMARK 3 T11: 0.0748 T22: 0.0723 REMARK 3 T33: 0.0466 T12: 0.0363 REMARK 3 T13: -0.0078 T23: -0.0288 REMARK 3 L TENSOR REMARK 3 L11: 1.1191 L22: 5.0090 REMARK 3 L33: 3.5937 L12: 0.2313 REMARK 3 L13: 0.5290 L23: -3.9571 REMARK 3 S TENSOR REMARK 3 S11: 0.0622 S12: -0.1148 S13: -0.0663 REMARK 3 S21: -0.1093 S22: -0.1312 S23: -0.1770 REMARK 3 S31: 0.1628 S32: 0.0428 S33: 0.0690 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C 1 C 12 REMARK 3 ORIGIN FOR THE GROUP (A): 32.216 -6.306 -9.288 REMARK 3 T TENSOR REMARK 3 T11: 0.0614 T22: 0.0713 REMARK 3 T33: 0.0450 T12: -0.0480 REMARK 3 T13: -0.0010 T23: 0.0230 REMARK 3 L TENSOR REMARK 3 L11: 5.3431 L22: 2.7253 REMARK 3 L33: 6.7798 L12: 0.9288 REMARK 3 L13: 5.7845 L23: 1.8045 REMARK 3 S TENSOR REMARK 3 S11: -0.3689 S12: 0.4506 S13: 0.3758 REMARK 3 S21: -0.2882 S22: 0.0078 S23: -0.1049 REMARK 3 S31: -0.4183 S32: 0.4012 S33: 0.3611 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 7KJN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-OCT-20. REMARK 100 THE DEPOSITION ID IS D_1000252577. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JAN-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 3311 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.14900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.87000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.350 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5UML REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4M SODIUM CHLORIDE, 5% ISOPROPANOL, REMARK 280 0.1M HEPES PH 7.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.03867 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 60.07733 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 60.07733 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 30.03867 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2250 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE D-PMI-OMEGA IS PEPTIDE-LIKE, A MEMBER OF INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: D-PMI-OMEGA REMARK 400 CHAIN: B, C REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 59 OD2 ASP A 79 2.08 REMARK 500 O GLN A 71 CE1 DTY B 4 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 43 114.28 -163.09 REMARK 500 ALA A 70 62.72 -174.45 REMARK 500 HIS A 72 -9.61 -168.90 REMARK 500 PRO A 95 43.46 -92.41 REMARK 500 DPN C 2 155.82 164.54 REMARK 500 DTR C 3 65.01 -80.48 REMARK 500 DVA C 5 83.33 52.36 REMARK 500 DGL C 6 -129.39 -137.26 REMARK 500 REMARK 500 REMARK: NULL DBREF 7KJN A 24 108 UNP O15151 MDM4_HUMAN 24 108 DBREF 7KJN B 1 12 PDB 7KJN 7KJN 1 12 DBREF 7KJN C 1 12 PDB 7KJN 7KJN 1 12 SEQADV 7KJN ALA A 68 UNP O15151 GLN 68 ENGINEERED MUTATION SEQADV 7KJN ALA A 69 UNP O15151 GLN 69 ENGINEERED MUTATION SEQADV 7KJN ALA A 70 UNP O15151 GLU 70 ENGINEERED MUTATION SEQRES 1 A 85 ILE ASN GLN VAL ARG PRO LYS LEU PRO LEU LEU LYS ILE SEQRES 2 A 85 LEU HIS ALA ALA GLY ALA GLN GLY GLU MET PHE THR VAL SEQRES 3 A 85 LYS GLU VAL MET HIS TYR LEU GLY GLN TYR ILE MET VAL SEQRES 4 A 85 LYS GLN LEU TYR ASP ALA ALA ALA GLN HIS MET VAL TYR SEQRES 5 A 85 CYS GLY GLY ASP LEU LEU GLY GLU LEU LEU GLY ARG GLN SEQRES 6 A 85 SER PHE SER VAL LYS ASP PRO SER PRO LEU TYR ASP MET SEQRES 7 A 85 LEU ARG LYS ASN LEU VAL THR SEQRES 1 B 12 DGL DPN DTR DTY DVA DGL D0C DGL DLY DLE DLE DAR SEQRES 1 C 12 DGL DPN DTR DTY DVA DGL D0C DGL DLY DLE DLE DAR HET DGL B 1 9 HET DPN B 2 11 HET DTR B 3 14 HET DTY B 4 12 HET DVA B 5 7 HET DGL B 6 9 HET D0C B 7 12 HET DGL B 8 9 HET DLY B 9 9 HET DLE B 10 8 HET DLE B 11 8 HET DAR B 12 12 HET DGL C 1 9 HET DPN C 2 11 HET DTR C 3 14 HET DTY C 4 12 HET DVA C 5 7 HET DGL C 6 9 HET D0C C 7 12 HET DGL C 8 9 HET DLY C 9 9 HET DLE C 10 8 HET DLE C 11 8 HET DAR C 12 12 HETNAM DGL D-GLUTAMIC ACID HETNAM DPN D-PHENYLALANINE HETNAM DTR D-TRYPTOPHAN HETNAM DTY D-TYROSINE HETNAM DVA D-VALINE HETNAM D0C 4-CHLORO-D-PHENYLALANINE HETNAM DLY D-LYSINE HETNAM DLE D-LEUCINE HETNAM DAR D-ARGININE FORMUL 2 DGL 6(C5 H9 N O4) FORMUL 2 DPN 2(C9 H11 N O2) FORMUL 2 DTR 2(C11 H12 N2 O2) FORMUL 2 DTY 2(C9 H11 N O3) FORMUL 2 DVA 2(C5 H11 N O2) FORMUL 2 D0C 2(C9 H10 CL N O2) FORMUL 2 DLY 2(C6 H14 N2 O2) FORMUL 2 DLE 4(C6 H13 N O2) FORMUL 2 DAR 2(C6 H15 N4 O2 1+) HELIX 1 AA1 LYS A 30 ALA A 40 1 11 HELIX 2 AA2 THR A 48 LYS A 63 1 16 HELIX 3 AA3 ASP A 79 GLY A 86 1 8 HELIX 4 AA4 PRO A 95 LYS A 104 1 10 HELIX 5 AA5 D0C B 7 DAR B 12 1 6 HELIX 6 AA6 DGL C 6 DAR C 12 1 7 SHEET 1 AA1 2 ARG A 28 PRO A 29 0 SHEET 2 AA1 2 LEU A 106 VAL A 107 -1 O VAL A 107 N ARG A 28 SHEET 1 AA2 2 MET A 73 VAL A 74 0 SHEET 2 AA2 2 PHE A 90 SER A 91 -1 O PHE A 90 N VAL A 74 LINK C DGL B 1 N DPN B 2 1555 1555 1.33 LINK C DPN B 2 N DTR B 3 1555 1555 1.33 LINK C DTR B 3 N DTY B 4 1555 1555 1.33 LINK C DTY B 4 N DVA B 5 1555 1555 1.34 LINK C DVA B 5 N DGL B 6 1555 1555 1.34 LINK C DGL B 6 N D0C B 7 1555 1555 1.33 LINK C D0C B 7 N DGL B 8 1555 1555 1.37 LINK C DGL B 8 N DLY B 9 1555 1555 1.33 LINK C DLY B 9 N DLE B 10 1555 1555 1.32 LINK C DLE B 10 N DLE B 11 1555 1555 1.32 LINK C DLE B 11 N DAR B 12 1555 1555 1.33 LINK C DGL C 1 N DPN C 2 1555 1555 1.33 LINK C DPN C 2 N DTR C 3 1555 1555 1.33 LINK C DTR C 3 N DTY C 4 1555 1555 1.33 LINK C DTY C 4 N DVA C 5 1555 1555 1.33 LINK C DVA C 5 N DGL C 6 1555 1555 1.31 LINK C DGL C 6 N D0C C 7 1555 1555 1.32 LINK C D0C C 7 N DGL C 8 1555 1555 1.33 LINK C DGL C 8 N DLY C 9 1555 1555 1.32 LINK C DLY C 9 N DLE C 10 1555 1555 1.33 LINK C DLE C 10 N DLE C 11 1555 1555 1.32 LINK C DLE C 11 N DAR C 12 1555 1555 1.33 CRYST1 48.849 48.849 90.116 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020471 0.011819 0.000000 0.00000 SCALE2 0.000000 0.023638 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011097 0.00000